Trust Investment Advisors Horizon Therapeutics Public LTD CO Transaction History

Trust Investment Advisors

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 22, 2022	SELL	$79.4 - $116.36 $243,996 - $357,574	-3,073 Closed	0 $0
Q1 2022 May 02, 2022	BUY	$86.42 - $109.81 $13,049 - $16,581	151 Added 5.17%	3,073 $323,000
Q4 2021 Feb 02, 2022	BUY	$98.56 - $119.91 $11,531 - $14,029	117 Added 4.17%	2,922 $315,000
Q3 2021 Nov 12, 2021	BUY	$91.91 - $110.37 $13,326 - $16,003	145 Added 5.45%	2,805 $307,000
Q2 2021 Jul 23, 2021	BUY	$86.24 - $95.92 $26,475 - $29,447	307 Added 13.05%	2,660 $249,000
Q1 2021 May 06, 2021	BUY	$71.83 - $95.48 $169,015 - $224,664	2,353 New	2,353 $217,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Trust Investment Advisors, based on Form 13F filings with the SEC.

Stay updated on Trust Investment Advisors with notifications on news.